The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ikonics Corp

Nasdaq: IKNX
Last

(U.S.) $7.90

Today's change+0.30 +3.95%
Updated November 17 3:49 PM -5GMT. Delayed by at least 15 minutes.
 

Ikonics Corp

Nasdaq: IKNX
Last

(U.S.) $7.90

Today's change+0.30 +3.95%
Updated November 17 3:49 PM -5GMT. Delayed by at least 15 minutes.

Ikonics Corp up sharply

Ikonics Corp closed up sharply Friday, rallying (U.S.)$0.30 or 3.95% to (U.S.)$7.90. Over the last five days, shares have gained 4.62%, but are down 29.78% for the last year to date. Shares have underperformed the S&P 500 by 44.90% during the last year.

Key company metrics

  • Open(U.S.) $7.82
  • Previous close(U.S.) $7.60
  • High(U.S.) $7.92
  • Low(U.S.) $7.60
  • Bid / Ask-- / --
  • YTD % change-29.78%
  • Volume10,713
  • Average volume (10-day)3,635
  • Average volume (1-month)2,689
  • Average volume (3-month)3,228
  • 52-week range(U.S.) $7.35 to (U.S.) $12.00
  • Beta0.32
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.29
Updated November 17 3:49 PM -5GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-3.45%

Ikonics Corp has a net profit margin of -3.45%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.40%Sector:Basic MaterialsIndustry:Chemicals - Specialty

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue4545
Total other revenue--------
Total revenue4545
Gross profit1112
Total cost of revenue3333
Total operating expense4545
Selling / general / administrative1121
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income00-10
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax00-10
Income after tax0000
Income tax, total0000
Net income0000
Total adjustments to net income--------
Net income before extra. items0000
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items0000
Inc. avail. to common incl. extra. items0000
Diluted net income0000
Dilution adjustment--------
Diluted weighted average shares2222
Diluted EPS excluding extraordinary itemsvalue per share-0.06-0.05-0.190.00
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.06-0.05-0.190.00